1. Caruso S, Rapisarda AMC, Cianci S. Sexuality in menopausal women. Curr Opin Psychiatry. 2016;29(6):323-30. [
DOI:10.1097/YCO.0000000000000280] [
PMID]
2. Holick MF. Resurrection of vitamin D deficiency and rickets. J Clin Invest. 2006;116(8):2062-72. [
DOI:10.1172/JCI29449] [
PMID] [
PMCID]
3. Bikle DD. Vitamin D: Production, Metabolism and Mechanisms of Action. In: Feingold KR, Anawalt B, Boyce A, et al., editors. Endotext. South Dartmouth (MA): MDText.com, Inc.; 2000.
4. DeLuca HF. Evolution of our understanding of vitamin D. Nutr Rev. 2008;66(10 Suppl 2):S73-87. [
DOI:10.1111/j.1753-4887.2008.00105.x] [
PMID]
5. Zhu J, DeLuca HF. Vitamin D 25-hydroxylase - Four decades of searching, are we there yet?. Arch Biochem Biophys. 2012;523(1):30-6. [
DOI:10.1016/j.abb.2012.01.013] [
PMID]
6. Snijder MB, van Dam RM, Visser M, Deeg DJ, Dekker JM, Bouter LM, et al. Adiposity in relation to vitamin D status and parathyroid hormone levels: A population-based study in older men and women. J Clin Endocrinol Metab. 2005;90(7):4119-23. [
DOI:10.1210/jc.2005-0216] [
PMID]
7. Pfotenhauer KM, Shubrook JH. Vitamin D deficiency, its role in health and disease, and current supplementation recommendations. J Am Osteopath Assoc. 2017;117(5):301-305. [
DOI:10.7556/jaoa.2017.055] [
PMID]
8. De Taeye B, Smith LH, Vaughan DE. Plasminogen activator inhibitor-1: a common denominator in obesity, diabetes and cardiovascular disease. Curr Opin Pharmacol. 2005;5(2):149-54. [
DOI:10.1016/j.coph.2005.01.007] [
PMID]
9. Fortenberry YM. Plasminogen activator inhibitor-1 inhibitors: a patent review (2006-present). Expert Opin Ther Pat. 2013;23(7):801-15. [
DOI:10.1517/13543776.2013.782393] [
PMID]
10. Blasi F, Carmeliet P. uPAR: a versatile signalling orchestrator. Nat Rev Mol Cell Biol. 2002;3(12):932-43. [
DOI:10.1038/nrm977] [
PMID]
11. Zhang L, Seiffert D, Fowler BJ, Jenkins GR, Thinnes TC, Loskutoff DJ, et al. Plasminogen has a broad extrahepatic distribution. Thromb Haemost. 2002;87(3):493-501. [
DOI:10.1055/s-0037-1613030] [
PMID]
12. Lapthorn AJ, Harris DC, Littlejohn A, Lustbader JW, Canfield RE, Machin KJ, et al. Crystal structure of human chorionic gonadotropin. Nature. 1994;369(6480):455-61. [
DOI:10.1038/369455a0] [
PMID]
13. Cole LA. Immunoassay of human chorionic gonadotropin, its free subunits, and metabolites. Clin Chem. 1997;43(12):2233-43. [
DOI:10.1093/clinchem/43.12.2233] [
PMID]
14. Stenman UH, Tiitinen A, Alfthan H, Valmu L. The classification, functions and clinical use of different isoforms of HCG. Hum Reprod Update. 2006;12(6):769-84. [
DOI:10.1093/humupd/dml029] [
PMID]
15. Vázquez-Lorente H, Herrera-Quintana L, Molina-López J, Gamarra-Morales Y, López-González B, Miralles-Adell C, et al. Response of vitamin D after magnesium intervention in a postmenopausal population from the province of Granada, Spain. Nutrients. 2020;12(8):2283. [
DOI:10.3390/nu12082283] [
PMID] [
PMCID]
16. Roberts H, Hickey M. Managing the menopause: an update. Maturitas. 2016;86:53-8. [
DOI:10.1016/j.maturitas.2016.01.007] [
PMID]
17. Fondjo LA, Sakyi SA, Owiredu WKBA, Laing EF, Owiredu E-W, Awusi Er K, et al. Evaluating Vitamin D Status in Pre- and Postmenopausal Type 2 Diabetics and Its Association with Glucose Homeostasis. Biomed Res Int. 2018:9369282. [
DOI:10.1155/2018/9369282] [
PMID] [
PMCID]
18. Kanwar SNG, Shekhawat M, Sharma P, Hada R. Comparison of vitamin D levels in Pre and PostMenopausal Type 2 diabetic females. IOSR JDMS. 2015;14(8):70-73.
19. Harlow SD, Gass M, Hall JE, Lobo R, Maki P, Rebar RW, et al. Executive summary of the Stages of Reproductive Aging Workshop + 10: addressing the unfinished agenda of staging reproductive aging. Menopause. 2012;19(4):387-395. [
DOI:10.1097/gme.0b013e31824d8f40] [
PMID] [
PMCID]
20. Bischoff-Ferrari HA, Borchers M, Gudat F, Dürmüller U, Stähelin HB, Dick W. Vitamin D receptor expression in human muscle tissue decreases with age. J Bone Miner Res. 2004;19(2):265-9. [
DOI:10.1359/jbmr.2004.19.2.265] [
PMID]
21. Schmitt EB, Nahas-Neto J, Bueloni-Dias F, Poloni PF, Orsatti CL, Petri Nahas EA. Vitamin D deficiency is associated with metabolic syndrome in postmenopausal women. Maturitas. 2018;107:97-102. [
DOI:10.1016/j.maturitas.2017.10.011] [
PMID]
22. Fondjo LA, Owiredu WKBA, Sakyi SA, Laing EF, Adotey-Kwofie MA, Antoh EO, Detoh E. Vitamin D status and its association with insulin resistance among type 2 diabetics: A case -control study in Ghana. PLOS One. 2017;12(4):e0175388. [
DOI:10.1371/journal.pone.0175388] [
PMID] [
PMCID]
23. Hantoosh HA, Mahdi MH, Imran BW, Yahya AA. Prevalence of vitamin D deficiency in Iraqi female at reproductive age. Med J Babylon. 2019;16(2):119-122. [
DOI:10.4103/MJBL.MJBL_9_19]
24. Amini S, Jafarirad S, Amani R. Postpartum depression and vitamin D: A systematic review. Crit Rev Food Sci Nutr. 2019;59(9):1514-1520. [
DOI:10.1080/10408398.2017.1423276] [
PMID]
25. Cermisoni GC, Alteri A, Corti L, Rabellotti E, Papaleo E, Viganò P, et al. Vitamin D and endometrium: A systematic review of a neglected area of research. Int J Mol Sci. 2018;19(8):2320. [
DOI:10.3390/ijms19082320] [
PMID] [
PMCID]
26. Al-Msaid HLF, AL-Sallami ASM. Study of Catsper1 protein levels in unexplained and idiopathic infertile men. The role of some biochemical markers and hormonal evidence in predisposition to osteoporosis in postmenopausal women. 2018;9(2):195-8. [
DOI:10.25258/ijpqa.v9i2.13646]
27. Holick MF. The vitamin D deficiency pandemic: approaches for diagnosis, treatment and prevention. Rev Endocr Metab Disord. 2017;18(2):153-65. [
DOI:10.1007/s11154-017-9424-1] [
PMID]
28. Mohammad S, Mishra A, Ashraf MZ. Emerging role of vitamin D and its associated molecules in pathways related to pathogenesis of thrombosis. Biomolecules. 2019;9(11):649. [
DOI:10.3390/biom9110649] [
PMID] [
PMCID]
29. Halder SK, Osteen KG, Al-Hendy A. 1,25-Dihydroxyvitamin d3 reduces extracellular matrix-associated protein expression in human uterine fibroid cells. Biol Reprod. 2013;89(6):150. [
DOI:10.1095/biolreprod.113.107714] [
PMID] [
PMCID]
30. Barbosa EM, Nonogaki S, Katayama ML, Folgueira MA, Alves VF, Brentani MM. Vitamin D3 modulation of plasminogen activator inhibitor type-1 in human breast carcinomas under organ culture. Virchows Arch. 2004;444(2):175-82. [
DOI:10.1007/s00428-003-0929-5] [
PMID]
31. Undas A, Ariëns RA. Fibrin clot structure and function: a role in the pathophysiology of arterial and venous thromboembolic diseases. Arterioscler Thromb Vasc Biol. 2011;31(12):e88-99. [
DOI:10.1161/ATVBAHA.111.230631]
32. Byrnes JR, Wolberg AS. Red blood cells in thrombosis. Blood. 2017;130(16):1795-1799. [
DOI:10.1182/blood-2017-03-745349] [
PMID] [
PMCID]
33. Hammer Y, Soudry A, Levi A, Talmor-Barkan Y, Leshem-Lev D, Singer J, et al. Effect of vitamin D on endothelial progenitor cells function. PLOS One. 2017;12(5):e0178057. [
DOI:10.1371/journal.pone.0178057] [
PMID] [
PMCID]
34. Gong ZH, Ji JF, Yang J, Xiang T, Zhou CK, Pan XL, et al. Association of plasminogen activator inhibitor-1 and vitamin D receptor expression with the risk of keloid disease in a Chinese population. Kaohsiung J Med Sci. 2017;33(1):24-29. [
DOI:10.1016/j.kjms.2016.10.013] [
PMID]
35. Badr Roomi A, Nori W, Mokram Hamed R. Lower Serum Irisin Levels Are Associated with Increased Osteoporosis and Oxidative Stress in Postmenopausal. Rep Biochem Mol Biol. 2021;10(1):13-19. [
DOI:10.52547/rbmb.10.1.13] [
PMID] [
PMCID]
36. Rashid FA, Mahdi S, Mahdy SA, Salim AT. Effect of Obesity on Plasma Alkaline Phosphatase Activity in Breast Cancer. Rep Biochem Mol Biol. 2021;10(2):307-313. [
DOI:10.52547/rbmb.10.2.307] [
PMID] [
PMCID]